These results were confirmed in two additional datasets: REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT)15 (P = 5.9 * 10−6, HR = 2.22, 95% C.I. [1.57, 3.14], n = 109 (Fig. 2d) and GSE1601116 (P = 0.0031, HR = 1.67, 95% C.I. [1.19, 2.35], n = 32 (Fig. 2e), suggesting that PDGFA expression is a prognostic biomarker in LGA. The gene discussed is PDGFA; the disease is neoplasm.